Clinical trials
Phase 1 Urologic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asan Medical Center | 2 |
| Celldex Therapeutics | 2 |
| GlaxoSmithKline | 2 |
| Wake Forest University Health Sciences | 2 |
| Biohaven Therapeutics Ltd. | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Emory University | 1 |
| Goldfinch Bio, Inc. | 1 |
| Humacyte, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urologic Diseases | 17 |
| Kidney Diseases | 10 |
| Renal Insufficiency | 5 |
| Carcinoma, Renal Cell | 4 |
| Kidney Neoplasms | 4 |
| Urologic Neoplasms | 4 |
| Neoplasms | 3 |
| Urogenital Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Glomerulonephritis | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.